Search

Displaying results 2161 - 2170 of 10000 in total
  1. Drug

    Rivipansel

    go.drugbank.com/drugs/DB12778
    Investigational

    Rivipansel has been used in trials studying the other, basic science, and treatment of Pain Crisis, Renal impairment, Anemia, Sickle Cell, Sickle Cell Disease, and Sickle Cell Disorders, among others.

    Synonyms: GMI-1070
  2. Drug

    Lutetium Lu-177

    go.drugbank.com/drugs/DB13982
    ApprovedInvestigational

    Products: Lutenca 40 GBq/ml Markerzubereitung, Lösung, ENDOLUCINBETA RADIOPHARMACEUTICAL PRECURSOR SOLUTION 40 GBQ/ML
  3. Drug

    Edrophonium

    go.drugbank.com/drugs/DB01010
    Approved

    It has also been used as an antidote to curare principles.

    Products: Enlon 10mg/ml, Enlon Liq IV 10mg/ml
  4. Drug

    Voglibose

    go.drugbank.com/drugs/DB04878
    Investigational

    It is made in India by Ranbaxy Labs and sold under the trade name Volix.

    Products: DIAVOG 0,2 MG EFERVESAN TABLET, 30 ADET, DIAVOG 0,2 MG EFERVESAN TABLET, 90 ADET
  5. Drug

    CXL-1020

    go.drugbank.com/drugs/DB15326
    Investigational

    CXL-1020 is under investigation in clinical trial NCT01092325 (Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure).

  6. Drug

    MYR-101

    go.drugbank.com/drugs/DB17075
    Investigational

    MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. … It is caused by a mutation in the aspartoacylase gene (_ASPA_), which leads to a deficiency of the aspartoacylase enzyme (ASPA).

  7. Drug

    MEM 1003

    go.drugbank.com/drugs/DB05547
    Investigational

    MEM 10003 was under investigation in clinical trial NCT00257673 (Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease) for the treatment of Alzheimer's Disease

  8. Drug

    Parnaparin

    go.drugbank.com/drugs/DB09260
    Approved

    Parnaparin is an heparin of low molecular weight with antithrombotic effects.

    Products: FLUXUM 0.3 ML 3200 IU 2 HAZIR SIRINGA, FLUXUM 0.3 ML 3200 IU 6 HAZIR SIRINGA
  9. Drug

    Cyclopentolate

    go.drugbank.com/drugs/DB00979
    Approved

    A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.

    Products: SİKLOMİD % 1 GÖZ DAMLASI, 5 ML, SIKLOPLEJIN %1 GÖZ DAMLASI, ÇÖZELTİ, 5 ML
  10. Drug

    Cilgavimab

    go.drugbank.com/drugs/DB16393
    ApprovedInvestigational

    may be exposed to the virus. … [L41549] In October 2022, the FDA and Health Canada released safety alerts regarding the risk of developing COVID-19 when exposed to SARS-CoV-2 variants not neutralized by EVUSHELD.